Alan Enriquez, MD
Clinical Cardiac Electrophysiology · New Haven, CTNPI 1639338676
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,000 of the $2,880 with a category attached, or 69.4%. Boston Scientific accounts for 89.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $2,000 and has fallen 83.6% since, to $329 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CT, where the typical reported total is $16,507.
Across 28 payments — averaging $102.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Impulse Dynamics (USA) Inc.$161
- Biosense Webster, Inc.$49
- Abbott$35
- Amgen$18
- Medtronic$18
- plus $16 from 1 others
What the payments were for
- Speaking & faculty fees$2,00069%
- Food & beverage$88031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 19 | $2,583 |
| Impulse Dynamics (USA) Inc. | 1 | $161 |
| Biosense Webster, Inc. | 4 | $49 |
| Abbott | 1 | $35 |
| Amgen | 1 | $18 |
| Medtronic | 1 | $18 |
| Cardiva Medical, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$2,000
- OPTIMIZER$322
How this compares
$2,880 in reported general payments places this provider in the 20th percentile of 47 clinical cardiac electrophysiology providers in Connecticut.
See all clinical cardiac electrophysiology providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 44 | $56,669 |
| MultaqDronedarone Hcl | 16 | $16,410 |
| Metoprolol Succinate | 62 | $782 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $437 |
| SotalolSotalol Hcl | 19 | $328 |
| Amiodarone Hcl | 13 | $198 |
| Metoprolol Tartrate | 27 | $182 |
| Bisoprolol Fumarate | 11 | $130 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in New Haven
- James FreemanNew Haven$87K
- Ralph DebiasiNew Haven$15K
- Bilal AyubNew Haven$14K
- James HummelNew Haven$2K
- Ilir MarajNew Haven$2K
- Anis KadadoNew Haven$2K
- Joseph Dell OrfanoHartford$160K
- Paras BhattNorwich$139K
- Steven ZweibelHartford$125K
- Murali ChiravuriFairfield$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.